The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...

Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

A warning about weight loss drugs and potential eye damage. Using GLP-1 medications is associated with an increased risk for ...